The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(6-methoxyquinolin-8-yl)-4-methyl-2-nitrobenzenesulfonamide ID: ALA269942
PubChem CID: 16759965
Max Phase: Preclinical
Molecular Formula: C17H15N3O5S
Molecular Weight: 373.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NS(=O)(=O)c2ccc(C)cc2[N+](=O)[O-])c2ncccc2c1
Standard InChI: InChI=1S/C17H15N3O5S/c1-11-5-6-16(15(8-11)20(21)22)26(23,24)19-14-10-13(25-2)9-12-4-3-7-18-17(12)14/h3-10,19H,1-2H3
Standard InChI Key: RPEDBQBZXNEPMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.9266 -20.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9266 -21.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6384 -21.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6384 -20.1711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3546 -20.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3511 -21.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0610 -21.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7791 -21.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0681 -20.1742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7800 -20.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7935 -18.9439 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.0717 -19.3500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5055 -19.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4924 -20.1894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1970 -20.6112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9191 -20.2121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9322 -19.3864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2233 -18.9600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1957 -18.2307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3738 -18.2307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6236 -20.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2341 -18.1338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5284 -17.7126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9517 -17.7333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4891 -21.8330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4857 -22.6547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
13 14 1 0
1 2 1 0
1 4 2 0
2 3 2 0
5 9 2 0
6 7 2 0
7 8 1 0
13 18 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
8 10 2 0
11 19 2 0
9 10 1 0
11 20 2 0
3 6 1 0
16 21 1 0
5 4 1 0
5 6 1 0
22 23 2 0
22 24 1 0
18 22 1 0
9 12 1 0
8 25 1 0
13 11 1 0
25 26 1 0
M CHG 2 22 1 24 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.39Molecular Weight (Monoisotopic): 373.0732AlogP: 3.26#Rotatable Bonds: 5Polar Surface Area: 111.43Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.75CX Basic pKa: 3.81CX LogP: 2.81CX LogD: 2.04Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -1.79
References 1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS.. (2008) Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation., 18 (1): [PMID:18024113 ] [10.1016/j.bmcl.2007.10.100 ] 2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW.. (2009) The first pharmacophore model for potent NF-kappaB inhibitors., 19 (19): [PMID:19726185 ] [10.1016/j.bmcl.2009.08.021 ]